Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

BBP ETF Forecast & Price Targets

Compare
See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

BBP Analyst Ratings

Moderate Buy
65ConsensusRatings
60Buy5Hold0Sell
Based on the Wall Street analyst consensus for 65 of BBP’s holdings.

BBP 12 Month Forecast

$152.50▲(44.14% Upside)
Based on Wall Street analyst 12-month price targets for 65 of Virtus LifeSci Biotech Products ETF’s holdings in the last 3 months. The average price target is $152.50 with a high forecast of $201.25 and a low forecast of $107.60. The average price target represents a 44.14% change from the last price of $105.80.
Highest Price Target$201.25Average Price Target$152.50Lowest Price Target$107.60

BBP Stocks With Highest Upside Potential

BBP highest upside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Strong Buy$13.43(318.34% Upside)
Strong Buy$4.33(249.46% Upside)
Strong Buy$14.57(205.48% Upside)
Strong Buy$38.29(188.95% Upside)
Strong Buy$26.82(168.69% Upside)

BBP Stocks With Highest Downside Potential

BBP highest downside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Hold$118.13(-51.20% Downside)
Hold$53.45(-16.98% Downside)
Moderate Buy$105.86(-14.89% Downside)
Moderate Buy$404.17(-7.92% Downside)
Hold$10.75(-5.95% Downside)

BBP ETF FAQ

What is BBP’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 65 of BBP’s holdings, Virtus LifeSci Biotech Products ETF’s 12-month average price target is $152.50.
What is BBP’s upside potential, based on the analysts’ average price target?
BBP’s average price target of $152.50 represents a 44.14% upside from its last price of $105.80.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BBP a Buy, Sell or Hold?
Virtus LifeSci Biotech Products ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 65 of BBP’s holdings: 60 rated Buy, 5 rated Hold and 0 rated Sell.
What is Virtus LifeSci Biotech Products ETF’s price target?
The average price target for Virtus LifeSci Biotech Products ETF is $152.50, based on Wall Street analyst 12-month price targets for 65 of BBP’s holdings, issued in the past 3 months. The highest price target is $201.25 and the lowest is $107.60. The average price target represents a 44.14% increase from the last price of $105.80.
What do analysts say about Virtus LifeSci Biotech Products ETF?
Virtus LifeSci Biotech Products ETF’s analyst rating consensus is Moderate Buy, based on Wall Street analyst ratings for 65 of BBP’s holdings.
How can I buy shares of BBP?
You can buy shares of BBP through a brokerage account. Compare brokers on our Best Online Brokers page.